State Street’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Hold |
|
|||||
|
2025
Q1 | $150K | Hold |
|
|||||
|
2024
Q4 | $336K | Buy |
|
|||||
|
2024
Q3 | $182K | Buy |
|
|||||
|
2024
Q2 | $125K | Sell |
|
|||||
|
2024
Q1 | $1.73M | Sell |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $3.73M | Sell |
|
|||||
|
2023
Q2 | $4.09M | Sell |
|
|||||
|
2023
Q1 | $23.9M | Buy |
|
|||||
|
2022
Q4 | $25.1M | Sell |
|
|||||
|
2022
Q3 | $30.6M | Buy |
|
|||||
|
2022
Q2 | $48.5M | Sell |
|
|||||
|
2022
Q1 | $58.3M | Buy |
|
|||||
|
2021
Q4 | $68.1M | Buy |
|
|||||
|
2021
Q3 | $67.7M | Sell |
|
|||||
|
2021
Q2 | $68M | Sell |
|
|||||
|
2021
Q1 | $63.4M | Buy |
|
|||||
|
2020
Q4 | $58.6M | Sell |
|
|||||
|
2020
Q3 | $41.9M | Sell |
|
|||||
|
2020
Q2 | $47.6M | Buy |
|
|||||
|
2020
Q1 | $19.1M | Buy |
|
|||||
|
2019
Q4 | $36.2M | Sell |
|
|||||
|
2019
Q3 | $36.8M | Buy |
|
|||||
|
2019
Q2 | $46.6M | Buy |
|
|||||
|
2019
Q1 | $67.3M | Buy |
|
|||||
|
2018
Q4 | $58.5M | Sell |
|
|||||
|
2018
Q3 | $87.1M | Buy |
|
|||||
|
2018
Q2 | $77.2M | Buy |
|
|||||
|
2018
Q1 | $78.3M | Buy |
|
|||||
|
2017
Q4 | $8.03M | Buy |
|
|||||
|
2017
Q3 | $7.14M | Buy |
|
|||||
|
2017
Q2 | $5.94M | Sell |
|
|||||
|
2017
Q1 | $12.6M | Buy |
|
|||||
|
2016
Q4 | $8.53M | Buy |
|
|||||
|
2016
Q3 | $7.89M | Buy |
|
|||||
|
2016
Q2 | $8M | Buy |
|
|||||
|
2016
Q1 | $5.08M | Sell |
|
|||||
|
2015
Q4 | $15.9M | Sell |
|
|||||
|
2015
Q3 | $24.3M | Buy |
|
|||||
|
2015
Q2 | $10.1M | Buy |
|
|||||
|
2015
Q1 | $2.97M | Buy |
|
|||||
|
2014
Q4 | $1.01M | Buy |
|